Fundz

TuHURA Biosciences Appoints Dr. Craig L. Tendler as Chief Medical Officer

PRIVATEMar 23, 2026

Position

Chief Medical Officer

Company

TuHURA Biosciences

Craig L. Tendler
TampaBiotechnologyHealthcareHealth CareTherapeutics

Description

TuHURA Biosciences announced the appointment of Dr. Craig L. Tendler to provide services consistent with those of a Chief Medical Officer

Quick answer

TuHURA Biosciences Appoints Dr. Craig L. Tendler as Chief Medical Officer (March 23, 2026). TuHURA Biosciences is based in Tampa, Florida, United States.

Who is the new Chief Medical Officer at TuHURA Biosciences?
TuHURA Biosciences named Craig L. Tendler Chief Medical Officer, announced March 23, 2026.
What did TuHURA Biosciences announce on March 23, 2026?
TuHURA Biosciences announced the appointment of Dr. Craig L. Tendler to provide services consistent with those of a Chief Medical Officer
What does TuHURA Biosciences do?
Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA Biosciences, Inc. TuHURA Biosciences, Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to...
Where is TuHURA Biosciences based?
TuHURA Biosciences is based in Tampa, Florida, United States.
Which similar companies made leadership changes around the same time?
Recursion Pharmaceuticals (March 25, 2026), Aquestive Therapeutics, Inc. (March 20, 2026), Korsana Biosciences (March 16, 2026) and Rhythm Pharmaceuticals (April 3, 2026) also announced leadership changes within 45 days of TuHURA Biosciences.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at TuHURA Biosciences, and when

A new leader at TuHURA Biosciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day TuHURA Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at TuHURA Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at TuHURA Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

TuHURA Biosciences

Location

10500 University Center Drive

Tampa, Florida, United States

About

Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA Biosciences, Inc. TuHURA Biosciences, Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company’s technologies are designed to overcome primary and acquired resistance to checkpoint inhibitors or cellular therapies in the treatment of cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment TuHURA Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

James
Likely contact at this company
••••••••@••••••••

See James's verified email →

Ian
Likely contact at this company
••••••••@••••••••

See Ian's verified email →

Marina
Likely contact at this company
••••••••@••••••••

See Marina's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for TuHURA Biosciences's next move

Learn about Strategic plan

TuHURA Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.